Health‐related quality of life · children with asthma
1 finding from 1 review
Intervention not reported
Intracranial pressure (mmHg) · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Intervention not reported
Mortality one month after the start of therapy · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Intervention not reported
Adverse effects considered as serious by either the patient or the clinician · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Intervention not reported
Disability (measured by the Glasgow Outcome Scale; higher score is better) · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Intervention not reported
Differences in quality of life ( · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review
Overall breast cancer incidence · women with above‐average risk of developing breast cancer
Tamoxifen probably leads to lower overall breast cancer incidence compared with placebo (moderate certainty).
1 finding from 1 review
Severe toxicity · women with above‐average risk of developing breast cancer
Tamoxifen probably leads to higher severe toxicity compared with placebo (moderate certainty).
1 finding from 1 review
Overall breast cancer incidence · women with above‐average risk of developing breast cancer
Aromatase inhibitors leads to lower overall breast cancer incidence compared with placebo (high certainty).
1 finding from 1 review
Severe toxicity · women with above‐average risk of developing breast cancer
Aromatase inhibitors leads to higher severe toxicity compared with placebo (high certainty).
1 finding from 1 review
Overall breast cancer incidence · women with above‐average risk of developing breast cancer
Aromatase inhibitors may leads to lower overall breast cancer incidence compared with tamoxifen (indirect comparison)a (low certainty).
1 finding from 1 review
Intervention not reported
Comparator · couples with unexplained infertility
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Comparator · couples with unexplained infertility
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Expectant management · couples with unexplained infertility
It is very uncertain whether the intervention changes expectant management (very low certainty).
1 finding from 1 review
OR 1.64 [0.99, 2.73]
Studies not reported
Very low
Intervention not reported
OS · couples with unexplained infertility
It is very uncertain whether the intervention changes OS (very low certainty).
1 finding from 1 review
OR 0.73 [0.38, 1.42]
Studies not reported
Very low
Intervention not reported
IUI · couples with unexplained infertility
It is very uncertain whether the intervention changes IUI (very low certainty).
1 finding from 1 review
OR 1.94 [1.05, 3.57]
Studies not reported
Very low
Intervention not reported
OS‐IUI · couples with unexplained infertility
The intervention showed no clear difference in OS‐IUI (low certainty).
1 finding from 1 review
OR 1.3 [0.68, 2.5]
Studies not reported
Low
Intervention not reported
Moderate/severe OHSS · couples with unexplained infertility
The intervention showed no clear difference in moderate/severe OHSS (moderate certainty).
1 finding from 1 review
Intervention not reported
Expectant management · couples with unexplained infertility
The intervention showed no clear difference in expectant management (low certainty).
1 finding from 1 review
OR 1.01 [0.51, 1.98]
Studies not reported
Low
Intervention not reported
OS · couples with unexplained infertility
The intervention showed no clear difference in OS (low certainty).
1 finding from 1 review
OR 1.2 [0.57, 2.52]
Studies not reported
Low